BP
Bruce D Perkins
Director

Bruce D Perkins insider trades: Amedisys (AMED) stock buys and sales

Director, Amedisys Last trade Sep 1, 2021 36 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2013
2
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Bruce reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 1, 2021AMED↓ Sell$2.1M
Mar 1, 2021AMED↑ Buy$259K
Jun 12, 2020AMED↑ Buy$335K
Mar 12, 2020AMED↑ Buy$306K
May 15, 2019AMED↑ Buy$280K
Aug 3, 2017AMED↑ Buy$93K
May 25, 2017AMED↑ Buy$30K
May 13, 2016AMED↑ Buy$50K
Jul 31, 2015AMED↑ Buy$129K
Aug 13, 2013HUM↓ Sell$841K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Bruce D Perkins's insider trades

Bruce D Perkins is a director at Amedisys (AMED). Since Aug 13, 2013, Bruce has reported 8 open-market purchases worth $1.5M and 2 sales worth $2.9M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (14 filings), gifts (5 filings), other transactions (5 filings), shares withheld for taxes (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AMED insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.